| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.70B | 55.53B | 52.61B | 50.84B | 48.21B | 49.50B |
| Gross Profit | 16.06B | 15.43B | 15.40B | 14.12B | 14.19B | 13.64B |
| EBITDA | 2.52B | 3.06B | 3.70B | 2.11B | 2.97B | 3.38B |
| Net Income | 614.46M | 510.81M | 1.07B | 9.90M | 741.10M | 1.22B |
Balance Sheet | ||||||
| Total Assets | 59.11B | 59.05B | 57.61B | 54.91B | 52.76B | 53.80B |
| Cash, Cash Equivalents and Short-Term Investments | 13.48B | 13.93B | 12.34B | 12.21B | 13.53B | 12.73B |
| Total Debt | 3.13B | 2.95B | 3.36B | 3.63B | 3.18B | 3.20B |
| Total Liabilities | 16.05B | 15.85B | 16.03B | 15.31B | 14.24B | 17.29B |
| Stockholders Equity | 40.84B | 40.89B | 39.26B | 36.66B | 35.79B | 33.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.98B | 1.50B | -758.81M | 1.27B | 358.29M |
| Operating Cash Flow | 0.00 | 3.28B | 3.28B | 951.64M | 2.58B | 1.59B |
| Investing Cash Flow | 0.00 | -1.53B | -1.23B | -1.18B | -811.51M | -1.08B |
| Financing Cash Flow | 0.00 | -1.92B | -2.30B | -1.24B | -922.64M | -381.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥40.59B | 15.65 | ― | 1.90% | 2.15% | 16.14% | |
76 Outperform | ¥90.26B | 12.64 | ― | 3.04% | 1.57% | -33.97% | |
74 Outperform | ¥39.50B | 26.79 | ― | 3.24% | 1.83% | -8.54% | |
67 Neutral | ¥38.66B | 16.63 | ― | 2.37% | -11.70% | -54.82% | |
66 Neutral | ¥35.12B | 33.75 | ― | 2.86% | -3.46% | -52.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ¥24.00B | -2.77 | ― | 3.23% | -0.45% | -3792.87% |